Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Add one to the list

posted on Sep 12, 2023 11:35AM

NCT05950464

Phase 1

Sponsored by NCI, collaborated by NRG Oncology

Recurrent ovarian and endometrial cancer

Combination Tuvusertib / Zen3694

Interestingly, Zenith is not listed as a collaborator or sponsor on this one.

4 Recommendations

Re: Add one to the list

Nextblockbuster

Sep 12, 2023 07:21PM

Re: Add one to the list

narmac

Sep 13, 2023 07:02AM

Re: Add one to the list

Nextblockbuster

Sep 13, 2023 10:17AM

Re: Add one to the list

KOO-KOO2

Sep 13, 2023 11:47AM

Re: Add one to the list

jonzobot

Sep 13, 2023 11:47AM

Re: Add one to the list

fuzzyjr

Sep 13, 2023 01:27PM

Reply New Message

Back To Forum List View

Please to post a reply